Your browser doesn't support javascript.
loading
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients.
Nakamura, Y; Namikawa, K; Yoshino, K; Yoshikawa, S; Uchi, H; Goto, K; Nakamura, Y; Fukushima, S; Kiniwa, Y; Takenouchi, T; Uhara, H; Kawai, T; Hatta, N; Funakoshi, T; Teramoto, Y; Otsuka, A; Doi, H; Ogata, D; Matsushita, S; Isei, T; Hayashi, T; Shibayama, Y; Yamazaki, N.
Afiliación
  • Nakamura Y; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan. Electronic address: ynakamur@saitama-med.ac.jp.
  • Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yoshino K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Yoshikawa S; Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Uchi H; Department of Dermatology, Kyushu University, Fukuoka, Japan.
  • Goto K; Department of Dermatology, Nagoya University, Nagoya, Japan.
  • Nakamura Y; Department of Dermatology, University of Tsukuba, Tsukuba, Japan.
  • Fukushima S; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Kiniwa Y; Department of Dermatology, Shinshu University, Matsumoto, Japan.
  • Takenouchi T; Department of Dermatology, Niigata Cancer Center, Niigata, Japan.
  • Uhara H; Department of Dermatology, Sapporo Medical University, Sapporo, Japan.
  • Kawai T; Department of Dermatology, University of Tokyo, Tokyo, Japan.
  • Hatta N; Department of Dermatology, Toyama Prefectural Central Hospital, Toyama, Japan.
  • Funakoshi T; Department of Dermatology, Keio University, Tokyo, Japan.
  • Teramoto Y; Department of Skin Oncology/Dermatology, Comprehensive Cancer Center, Saitama Medical University International Medical Center, Saitama, Japan.
  • Otsuka A; Department of Dermatology, Kyoto University, Kyoto, Japan.
  • Doi H; Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.
  • Ogata D; Department of Dermatology, Saitama Medical University, Saitama, Japan.
  • Matsushita S; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
  • Isei T; Department of Dermatological Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Hayashi T; Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Shibayama Y; Department of Dermatology, Fukuoka University, Fukuoka, Japan.
  • Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ann Oncol ; 31(9): 1198-1206, 2020 09.
Article en En | MEDLINE | ID: mdl-32522691
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article